Long-term erythropoietin therapy improves response in myelodysplastic syndrome.
Ohshima M, Ubara Y, Tagami T, Sawa N, Suwabe T, Yamakawa K, Hoshino J, Katori H, Takemoto F, Hara S, Miyakoshi J, Takaichi K.
Ohshima M, et al. Among authors: hoshino j.
Ther Apher Dial. 2005 Aug;9(4):362-6. doi: 10.1111/j.1744-9987.2005.00298.x.
Ther Apher Dial. 2005.
PMID: 16076383